The collaboration aims to provide mid-market clients with an integrated solution that addresses the complexities of ...

Ochre Bio, a biotechnology company developing RNA therapeutics for chronic liver disease, today announced the successful completion of the research phase of its collaboration with GSK, delivering two ...

As part of broader financial adjustment measures, Aiforia Technologies announced on October 31, 2025, that it will start change negotiations. The objective of the financial adjustment measures is to ...